Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Update Il y a 4 ans
Reference: NCT01215110

Woman and Man

Extract

The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of TMC207 at multiple doses as determined by the rate of change of log10 colony forming units (CFU) per ml sputum over the time period Day 7-14 in participants with smear positive pulmonary tuberculosis (TB). A control group will receive standard treatment.


Inclusion criteria

  • Pulmonary tuberculosis

Links